FDA Approved: SILODOSIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original application for silodosin from Aurobindo Pharma Limited as a generic treatment for symptoms of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

ORIG AP for SILODOSIN (SILODOSIN)